This review aims at a coherent summary of the results obtained from various studies that concern analgesic-like activity of the extracts of H. preforatum L. and thirteen other Hypericum L. species (Hypericaceae). Botanical origin, plant organs and extraction modes of the plant material, experimental models, routes of administration and doses used for animal treatment are summarized. Mechanisms of action and substances (and even the synergy thereof) proposed so far to be responsible for the observed activity have also been discussed. Even though St. John's wort (H. perforatum) is the most renowned plant species of this genus, it is neither the only nor the most potent one in inducing pain relief.
(a) HölzlJ., PetersenM. (2003) Hypericum: the Genus Hypericum.Taylor & Francis, London, 77–93; (b) Barnes J, Anderson LA, Phillipson JD. (2001) St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. Journal of Pharmacy and Pharmacology, 53, 583–600; (c) Crockett SL. (2010) Essential oil and volatile components of the genus Hypericum (Hypericaceae). Natural Product Communications, 5, 1493–1506.
2.
(a) RadulovićN.S., DjordjevićA.S., PalićR.M. (2010) The intrasectional chemotaxonomic placement of Hypericum elegans Stephan ex Willd. inferred from the essential-oil chemical composition. Chemistry & Biodiversity, 7, 943–952;(b) Radulović N, Đordević A, Palić R, Zlatković B. (2010) Essential oil composition of Hypericum annulatum Moris (Hypericaceae) from Serbia. Journal of Essential Oil Research, 22, 619–624; (c) Radulović NS, Blagojević PD. (2012) Chemical composition of Hypericum rumeliacum Boiss. essential oil. A new chemotype of this pharmacologically valuable species? Chemistry & Biodiversity, 9, 2324–2341.
3.
(a) RadulovićN., Stankov-JovanovićV., StojanovićG., SmelcerovićA., SpitellerM., AsakawaY. (2007) Screening of in vitro antimicrobial and antioxidant activity of nine Hypericum species from the Balkans. Food Chemistry, 103, 15–21;(b) Fico G, Vitalini S, Colombo N, Tomè F. (2006) Hypericum perforatum L., H. maculatum Crantz., H. calycinum L. and H. pulchrum L.: phytochemical and morphological studies. Natural Product Communications, 1, 1129–1132; (c) Piovan A, Filippini R, Caniato R. (2010) A semi-quantitative FIA-ESI-MS method for the rapid screening of Hypericum perforatum crude extracts. Natural Product Communications, 5, 431–434; (d) Odabas MS, Camas N, Cirak C, Radušiene J, Janulis V, Ivanauskas L. (2010) The quantitative effects of temperature and light intensity on phenolics accumulation in St. John's Wort (Hypericum perforatum). Natural Product Communications, 5, 535–540; (e) Bagdonaite E, Janulis V, Ivanauskas L, Labokas J. (2012) Between species diversity of Hypericum perforatum and H. maculatum by the content of bioactive compounds, Natural Product Communications, 7, 199–200; (f) Muszyńska B, Ekiert H, Kwiecień I, Maślanka A, Zodi R, Beerhues L. (2014) Comparative analysis of therapeutically important indole compounds in in vitro cultures of Hypericum perforatum cultivars by HPLC and TLC analysis coupled with densitometric detection, Natural Product Communications, 9, 1437–1440.
4.
NewallC.A., AndersonL.A., PhillipsonJ.D. (1996) Herbal Medicines. A Guide for Health-care Professionals.Pharmaceutical Press, London.
DongmeiW., JieB., FengS., DepoY. (2010) Chemical constituents and antidepressant activity of the new species Hypericum enshiense occurring in China. Phytomedicine, 17, 410–413.
7.
AnilK., AnantS. (2007) Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Planta Medica, 73, 1358–1364.
8.
MumtazA., MohammadA., HabibA., KhairZ., FarhatullahK., RyszardA. (2011) Comparative antioxidant and antimicrobial activities of phenolic compounds extracted from five Hypericum species. Food Technology and Biotechnology, 49, 205–213.
9.
BirtD.F., WidrlechnerM.P., HammerK.D., HillwigM.L., WeiJ., KrausG.A., MurphyP.A., McCoyJ., WurteleE.S., NeighborsJ.D., WiemerD.F., MauryW.J., PriceJ.P. (2009) Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharmaceutical Biology, 47, 774–782.
10.
Arif-ullahK., Anwarul-HassanG., RehmanN. (2011) Pharmacological studies on Hypericum perforatum fractions and constituents. Pharmaceutical Biology, 49, 46–56.
11.
(a) MohammadA., MumtazA., HabibA., ItratA., AjmalK., IqbalC.M., RazaS.M. (2010) Urease inhibitors from Hypericum oblongifolium Wall. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 296–299;(b) Luo L, Sun Q, Mao YY, Lu YH, Tan RX. (2004) Inhibitory effects of flavonoids from Hypericum perforatum on nitric oxide synthase. Journal of Ethnopharmacology, 93, 221–225.
12.
SchmidtkoA., TegederI., GeisslingerG. (2009) No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends in Neurosciences, 32, 339–346.
13.
StamfordJ.A. (1995) Descending control of pain. British Journal of Anesthesia, 75, 212–227.
14.
(a) SherwoodL. (2010) Human Physiology: From Cells to Systems.Brooks Cole, Salt Lake City; (b) Noda M, Teranishi Y, Takahashi H, Toyosato M, Notake M, Nakanishi S, Numa S. (1982) Isolation and structural organization of the human preproenkephalin gene. Nature, 297, 431–434; (c) Radulović NS, Blagojević PD, Randjelović PJ, Stojanović NM. (2013) The last decade of antinociceptive alkaloids: Structure, synthesis, mechanism of action and prospect. Current Topics in Medicinal Chemistry, 13, 2134–2170.
15.
McDougallJ.J. (2011) Peripheral analgesia: Hitting pain where it hurts. Biochimica et Biophysica Acta, 1812, 459–467.
16.
(a) DubuissonD., DennisS.G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain, 4, 161–174;(b) Hunskaar S, Fasmer OB, Hole K. (1985) Formalin test in mice, a useful technique for evaluating mild analgesics. Journal Neuroscience Methods, 14, 69–76; (c) Tjolsen A, Berge O, Hunskaar S, Rosland JH, Hole K. (1992) The formalin test: an evaluation of the method. Pain, 51, 5–17.
17.
RamabadranK., BansinathM., TurndorfH., PuigM.M. (1989) Tail immersion test for the evaluation of a nociceptive reaction in mice. Methodological considerations. Journal of Pharmacological Methods, 21, 21–31.
18.
Le BrasD., GozariuM., CaddenS.W. (2001) Animal models of nociception. Pharmacological Reviews, 53, 597–652.
19.
(a) GaleottiN., VivoliE., BiliaA.R., Camilla BergonziM., BartoliniA., GhelardiniC. (2010) A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of St. John's wort in mice. The Journal of Pain, 11, 149–159;(b) Morteza-Semnani K, Mahmoudi M, Saeedi M, Javanmardi A. (2003) Analgesic activity of Iranian Hypericum perforatum. Toxicology Letters, 144, s88; (c) Kumar V, Singht PN, Bhattacharya SK. (2001) Anti-inflammatory and analgesic activity of Indian H. perforatum. Indian Journal of Experimental Biology, 39, 339–343; (d) Abdel-Salam OME. (2005) Anti-inflammatory, antinociceptive, and gastric effects of Hypericum perforatum in rats. The Scientific World Journal, 5, 585–596; (e) Subhan F, Kahan M, Ibrar M, Nazar-ul-Islam, Kahan A, Gilani AH. (2007) Antagonism of antinociceptive effect on hydro-ethanolic extract of Hypericum perforatum Linn. by a selective opioid receptor antagonist, naloxone. Pakistan Journal of Biological Sciences, 10, 792–796; (f) Bukahri IA, Dar A, Khan RA. (2004) Antinociceptive activity of methanolic extracts of St. John's wort (Hypericum perforatum) preparation. Pakistan Journal of Pharmaceutical Sciences, 17, 13–19; (g) Uchida S, Hirai K, Hatanaka J, Hanato J, Umegaki K, Yamada S. (2008) Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and grape seed proanthocyanidins extract in mice. Biological and Pharmaceutical Bulletin, 31, 240–245; (h) Oztürk Y, Aydin S, Beis R, Can Baser KH, Berberoglu H. (1996) Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice. Phytomedicine, 3, 139–146; (i) Biranvand F, Khaksarian M. (2005) The effects of peripheral and central administration of Hypericum perforatum L. on chronic and acute pain in male rats. Pakistan Journal of Biological Sciences, 8, 949–953; (j) Can ÖD, Öztürk Y, Öztürk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F. (2011) Effects of treatment with St. John's wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats. Fitoterapia, 82, 576–584; k) Galeotti N, Maidecchi A, Mattoli L, Burico M, Ghelardini C. (2013) St. John's wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes. Fitoterapia, 92, 23–33; (l) Galeotti N, Ghelardini C. (2013) St. John's wort reversal of meningeal nociception: A natural therapeutic perspective for migraine pain. Phytomedicine, 20, 930–938.
20.
(a) PerazzoF.F., LimaL.M., de Mesquita PadilhaM., RochaL.M., SousaP.J.C., CarvalhoJ.C.T. (2008) Anti-inflammatory and analgesic activities of Hypericum brasiliense (Willd) standardized extract. Brazilian Journal of Pharmacognosy, 18, 320–325;(b) Mendes FR, Mattei R, De Araujo Carlini EL. (2002) Activity of Hypericum brasiliense and Hypericum cordatum on the central nervous system in rodents. Fitoterapia, 73, 462–471; (c) Oztürk Y, Aydin S, Beis R, Baser KHC, Berberoglu H. (1996) Effects of Hypericum calycinum L. extract on the central nervous system in mice. Phytotherapy Research, 10, 700–702; d) Rabanal ARM, Bonkanka CX, Hernández-Pérez M, Sánchez-Mateo CC. (2005) Analgesic and topical anti-inflammatory activity of Hypericum canariense L. and Hypericum glandulosum Ait. extracts in the forced swimming test in mice. Journal of Ethnopharmacology, 96, 591–596; (e) Viana AF, Heckler AP, Fenner R, Rates SMK. (2003) Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum (Guttiferae). Brazilian Journal of Medical and Biological Research, 36, 631–634; (f) Vianaa AF, do Rego JC, Munari L, Dourmap N, Heckler AP, Dalla Costa T, Von Poser GL, Costentin J, Rates SMK. (2006) Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activity. Fundamental & Clinical Pharmacology, 20, 507–514; (g) Haas JS, Stolz ED, Betti AH, Stein AC, Schripsema J, von Poser GL, Rates SMK. (2011) The anti-immobility effect of hyperoside on the forced swimming test in rats is mediated by the D2 – like receptors activation. Planta Medica, 77, 334–339; (h) Trovato A, Raneri E, Kouladis M, Tzakou O, Taviano MF, Galati EM. (2001) Anti-inflammatory and analgesic activity of Hypericum empetrifolium Willd. (Guttiferae). Il Farmaco, 56, 455–457; (i) Bonkanka CX, Sánchez-Mateo CC, Rabanal RM. (2011) Antinociceptive activity of Hypericum grandifolium Choisy in mice. Journal of Natural Medicines, 65, 122–128; (j) Stolz ED, Viana AF, Hasse DR, von Poser GL, do Rego JC, Rates SMK. (2012) Uliginosin B presents antinociceptive effect mediated by dopaminergic and opioid systems in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 80–87; (k) Yaşar ŞN, Devrim Can Ö, Öztürk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F. (2013) Central nervous system activities of Hypericum origanifolium extract via GABAergic and opioidergic mechanisms. Phytotherapy Research, 27, 877–884; (l) Haas JS, Viana AF, Heckler APM, von Poser GL, Rates SMK. (2010) The antinociceptive effect of benzopyrane (HP1) isolated from Hypericum polyanthemum in mice hot-plate test is blocked by naloxone. Planta Medica, 76, 1419–1423; (m) Sánchez-Mateo CC, Bonkanka CX, Hernández-Pérez M, Rabanal RM. (2006) Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. fil. Journal of Ethnopharmacology, 107, 1–6; (n) Apaydιn S, Zeybek U, Ince I, Elgin G, Karamenderes C, Ozturk B, Tuglular I. (1999) Hypericum triquetrifolium Turra. extract exhibits antinociceptive activity in the mouse. Journal of Ethnopharmacology, 67, 307–312.
21.
KhanG.M., ChenS.R., PanH.L. (2002) Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience, 114, 291–299.
22.
GertschJ. (2011) Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Planta Medica, 77, 1086–1098.
23.
IsacchiB., GaleottiN., BergonziM.C., GhelardiniC., BiliaA.R., VincieriF.F. (2009) Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations. Phytotherapy Research, 23, 197–205.
24.
KitanovG.M. (2001) Hypericin and pseudohypericin in some Hypericum species. Biochemical Systematics and Ecology, 38, 171–178.
25.
StolzaE.D., MüllerL.G., AntonioC.B., da CostaP.F., von PoserG.L., NoëlF., RatesS.M.K. (2014) Determination of pharmacological interactions of uliginosin B, a natural phloroglucinol derivative, with amitriptyline, clonidine and morphine by isobolographic analysis. Phytomedicine, 21, 1684–1688.
26.
SimmenU., HigelinJ., Berger-BüterK., SchaffnerW., LundstromK. (2001) Neurochemical studies with St. John's wort in vitro. Pharmacopsychiatry, 34, 137–142.
27.
(a) PerovicS., MüllerW.E. (1995) Pharmacological profile of Hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung, 45, 1145–1148;(b) Rolli M, Schafer C, Müller WE. (1997) Effect of Hypericum extract LI 160 on neurotransmitter receptor binding and synaptosomal uptake systems. Pharmacopsychiatry, 30, 102–107; (c) Teufel-Mayer R, Gleitz J. (1997) Effects of long-term administration of Hypericum extracts on the affinity and density of the central serotonergic 5-HT1A and 5-HT2A receptors. Pharmacopsychiatry, 30, 113–116.
28.
(a) BombardelliE., MorazzoniP. (1995) Hypericum perforatum. Fitoterapia, 66, 43–68;(b) Mennini T, Gobbi M. (2004) The antidepressant mechanism of Hypericum perforatum. Life Sciences, 75, 1021–1027; (c) Gnerre C, von Poser GL, Ferraz A, Viana A, Testa B, Rates SMK. (2001) Monoamine oxidase inhibitory activity of some Hypericum species native to South Brazil. Journal of Pharmacy and Pharmacology, 53, 1273–1279.
29.
(a) StolzE.D., HasseD.R., von PoserG.L., RatesS.M.K. (2014) Uliginosin B, a natural phloroglucinol derivative, presents a multimediated antinociceptive effect in mice. Journal of Pharmacy and Pharmacology, 66, 1774–1785;(b) Stein AC, Viana AF, Müller LG, Nunes JM, Stolz ED, Do Rego JC, Costentin J, von Poser GL, Rates SMK. (2012) Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: A promising new molecular pattern for the development of antidepressant drugs. Behavioural Brain Research, 228, 66–73.
30.
TaiwoY.O., FabianA., PazolesC.J., FieldsH.L. (1985) Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain, 21, 329–337.
31.
GilaniA.H., KhanA., SubhanF., KhanM. (2005) Antispasmodic and bronchodilator activities of St. John's wort are putatively mediated through dual inhibition of calcium influx and phosphodiesterases. Fundamental & Clinical Pharmacology, 19, 695–705.
32.
KristhalO., LozovayaN., FisunovA., TsintsaadzeT., PankratovY., KopanistaM., ChatterjeeS.S. (2001) Modulation of ion channels in rat neurons by Hypericum perforatum. Pharmacopsychiatry, 34, 74–82.
33.
SauviatM.P., ColasA., ChauveauM.J., DrapierJ.C., NégrerieM. (2007) Hypericin activates L-type Ca2+ channels in cardiac myocytes. Journal of Natural Products, 70, 510–514.
34.
WangY., ShiX., QiZ. (2010) Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels. British Journal of Pharmacology, 159, 1402–1407.
35.
ZanoliP. (2004) Role of hyperforin in the pharmacological activities of St. John's wort. CNS Drug Reviews, 10, 203–218.
36.
GaleottiN., VivoliE., BiliaA.R., VincieriF.F., GhelardiniC. (2010) St. John's wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase C γ and ε activity. Biochemical Pharmacology, 79, 1327–1336.
